Mesoblast (MESO) Inventory (2024 - 2026)
Mesoblast (MESO) posted Inventory of $21.7 million for Q4 2025, down 2.62% sequentially from $22.2 million in Q2 2025, and down 10.46% YoY from $24.2 million in Q4 2024.
Powered by 
Analysis
Mesoblast (MESO) Inventory (2024 - 2026) Analysis & Trends
Mesoblast has reported Inventory for 2 years, with the latest figure at $21.7 million in Q4 2025.
- Quarterly Inventory fell 10.46% year-over-year to $21.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $21.7 million (down 10.46% YoY) and the FY2025 annual result came in at $22.2 million, changed N/A from the prior year.
- Inventory eased to $21.7 million in Q4 2025 per MESO's latest filing, from $22.2 million in the prior quarter.
- Over five years, Inventory peaked at $24.2 million in Q4 2024 and troughed at $21.7 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 280.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 732.60 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 97.11 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Mesoblast | 2.24 Bn | 2.14 Bn | - | 28.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.11 Mn |
| Dec 31, 2025 | 21.66 Mn |
| Jun 30, 2025 | 22.25 Mn |
| Dec 31, 2024 | 24.19 Mn |